266 related articles for article (PubMed ID: 33152819)
1. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
[No Abstract] [Full Text] [Related]
2. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
3. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
4. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
[TBL] [Abstract][Full Text] [Related]
6. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.
Viswanathan K; Beg S; He B; Zhang T; Cantley R; Lubin DJ; Shi Q; Maleki Z; Asiry S; Rao R; Katabi N; Nakaguro M; Faquin WC; Sadow PM; Siddiqui MT; Scognamiglio T
Am J Clin Pathol; 2022 Jan; 157(1):98-108. PubMed ID: 34508546
[TBL] [Abstract][Full Text] [Related]
7. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
Skaugen JM; Seethala RR; Chiosea SI; Landau MS
Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
[TBL] [Abstract][Full Text] [Related]
9. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
Abd Raboh NM; Hakim SA
Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
[TBL] [Abstract][Full Text] [Related]
11. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
Shi Q; Zhang B; Bsirini C; Li L; Giampoli EJ; Magliocca KR; Reid M; Zhou Z
Hum Pathol; 2022 Sep; 127():86-91. PubMed ID: 35700750
[TBL] [Abstract][Full Text] [Related]
12. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
13. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract][Full Text] [Related]
14. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
15. Expression of SOX10 in Salivary Gland Oncocytic Neoplasms: A Review and a Comparative Analysis with Other Immunohistochemical Markers.
Schmitt AC; Cohen C; Siddiqui MT
Acta Cytol; 2015; 59(5):384-90. PubMed ID: 26619208
[TBL] [Abstract][Full Text] [Related]
16. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
[TBL] [Abstract][Full Text] [Related]
17. Morphologic and Ancillary Studies of Pediatric Acinic Cell Carcinoma: A Single Institute Experience.
Cole GG; Salgado CM; Vargas de Stefano D; Zambrano EV; Gómez AM; Reyes-Múgica M; Wang Q
Head Neck Pathol; 2023 Mar; 17(1):204-209. PubMed ID: 36169793
[TBL] [Abstract][Full Text] [Related]
18. Head and Neck Acinic Cell Carcinoma: A New Grading System Proposal and Diagnostic Utility of NR4A3 Immunohistochemistry.
Xu B; Saliba M; Ho A; Viswanathan K; Alzumaili B; Dogan S; Ghossein R; Katabi N
Am J Surg Pathol; 2022 Jul; 46(7):933-941. PubMed ID: 35034042
[TBL] [Abstract][Full Text] [Related]
19. DOG1: a novel marker of salivary acinar and intercalated duct differentiation.
Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR
Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.
Wang H; Zhai C; Zhang C; Liu Q; Zhang H; Sun X; Lin L; Yu H; Wang D
Mod Pathol; 2022 May; 35(5):594-600. PubMed ID: 34873305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
